Design Therapeutics, Inc. (DSGN)

Design Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22.56	21.2	26.5	298.57	2.38
Short-Term Investments	222.91	260.6	303.89	85.5	33.71
Cash & Short-Term Investments	245.48	281.8	330.39	384.06	36.09
Cash Growth	-12.89%	-14.71%	-13.98%	964.15%	46771.43%
Other Receivables	1.26	1.43	1.12	0.11	0.01
Receivables	1.26	1.43	1.12	0.11	0.01
Prepaid Expenses	1.3	1.35	3.62	1.26	0.06
Other Current Assets	-	-	-	-	0.07
Total Current Assets	248.04	284.58	335.12	385.44	36.23
Property, Plant & Equipment	3.63	4.63	5.56	5.12	0.07
Long-Term Deferred Charges	-	-	-	-	0.21
Other Long-Term Assets	0.43	0.43	0.46	-	-
Total Assets	252.09	289.64	341.14	390.56	36.52
Accounts Payable	2.19	1.94	3.03	1.62	1.4
Accrued Expenses	5.48	6.97	7.11	3.17	0.93
Current Portion of Leases	0.8	0.72	0.64	0.49	-
Total Current Liabilities	8.46	9.62	10.78	5.28	2.33
Long-Term Leases	1.53	2.33	3.05	3.14	-
Other Long-Term Liabilities	-	-	-	-	0.15
Total Liabilities	10	11.96	13.83	8.43	2.48
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	468.83	455.25	441.42	429.82	0.45
Retained Earnings	-227.21	-177.63	-110.76	-47.46	-11.92
Comprehensive Income & Other	0.48	0.06	-3.36	-0.24	0.16
Total Common Equity	242.1	277.69	327.31	382.13	-11.32
Shareholders' Equity	242.1	277.69	327.31	382.13	34.04
Total Liabilities & Equity	252.09	289.64	341.14	390.56	36.52
Total Debt	2.33	3.05	3.69	3.63	-
Net Cash (Debt)	243.14	278.75	326.7	380.43	36.09
Net Cash Growth	-12.77%	-14.68%	-14.12%	954.09%	-
Net Cash Per Share	4.30	4.98	5.86	8.28	2.28
Filing Date Shares Outstanding	56.76	56.49	55.9	55.46	15.96
Total Common Shares Outstanding	56.75	56.47	55.9	55.44	15.96
Working Capital	239.58	274.96	324.34	380.15	33.9
Book Value Per Share	4.27	4.92	5.86	6.89	-0.71
Tangible Book Value	242.1	277.69	327.31	382.13	-11.32
Tangible Book Value Per Share	4.27	4.92	5.86	6.89	-0.71
Machinery	2.91	2.6	2.32	1.54	0.08
Construction In Progress	-	-	-	0.01	-
Leasehold Improvements	0.15	0.15	0.15	0.1	-

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q